期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus(2019-nCoV) infected pneumonia(standard version) 被引量:158
1
作者 Ying-Hui Jin Lin Cai +44 位作者 Zhen-Shun Cheng Hong Cheng Tong Deng Yi-Pin Fan Cheng Fang Di Huang Lu-Qi Huang Qiao Huang Yong Han Bo Hu Fen Hu Bing-Hui Li Yi-Rong Li Ke Liang Li-Kai Lin Li-Sha Luo Jing Ma Lin-Lu Ma Zhi-Yong Peng Yun-Bao Pan Zhen-Yu Pan Xue-Qun Ren Hui-Min Sun Ying Wang Yun-Yun Wang Hong Weng Chao-Jie Wei Dong-Fang Wu Jian Xia Yong Xiong Hai-Bo Xu Xiao-Mei Yao Yu-Feng Yuan Tai-Sheng Ye Xiao-Chun zhang ying-wen zhang Yin-Gao zhang Hua-Min zhang Yan Zhao Ming-Juan Zhao Hao Zi Xian-Tao Zeng Yong-Yan Wang Xing-Huan Wang 《Military Medical Research》 SCIE CAS CSCD 2020年第1期1-22,共22页
In December 2019, a new type viral pneumonia cases occurred in Wuhan, Hubei Province;and then named "2019 novel coronavirus(2019-nCoV)" by the World Health Organization(WHO) on 12 January 2020. For it is a n... In December 2019, a new type viral pneumonia cases occurred in Wuhan, Hubei Province;and then named "2019 novel coronavirus(2019-nCoV)" by the World Health Organization(WHO) on 12 January 2020. For it is a never been experienced respiratory disease before and with infection ability widely and quickly, it attracted the world’s attention but without treatment and control manual. For the request from frontline clinicians and public health professionals of 2019-nCoV infected pneumonia management, an evidence-based guideline urgently needs to be developed. Therefore, we drafted this guideline according to the rapid advice guidelines methodology and general rules of WHO guideline development;we also added the first-hand management data of Zhongnan Hospital of Wuhan University. This guideline includes the guideline methodology, epidemiological characteristics, disease screening and population prevention, diagnosis, treatment and control(including traditional Chinese Medicine), nosocomial infection prevention and control, and disease nursing of the 2019-nCoV. Moreover, we also provide a whole process of a successful treatment case of the severe 2019-nCoV infected pneumonia and experience and lessons of hospital rescue for 2019-nCoV infections. This rapid advice guideline is suitable for the first frontline doctors and nurses, managers of hospitals and healthcare sections, community residents, public health persons, relevant researchers, and all person who are interested in the 2019-nCoV. 展开更多
关键词 2019 novel coronavirus 2019-nCoV Respiratory disease PNEUMONIA Infectious diseases Rapid advice guideline Clinical practice guideline Evidence-based medicine
下载PDF
Energy-optimal problem of multiple nonholonomic wheeled mobile robots via distributed event-triggered optimization algorithm 被引量:1
2
作者 ying-wen zhang Jin-Huan Wang +1 位作者 Yong Xu De-Dong Yang 《Chinese Physics B》 SCIE EI CAS CSCD 2019年第3期122-129,共8页
The distributed event-triggered optimization problem for multiple nonholonomic robots has been studied to minimize the global battery energy consumption. Each robot possesses its own cost function which depends on the... The distributed event-triggered optimization problem for multiple nonholonomic robots has been studied to minimize the global battery energy consumption. Each robot possesses its own cost function which depends on the state of the hand position and represents battery energy consumption. By coordinate transformation, the dynamics of the hand positions can be formulated into two groups of first-order integrators. Then the distributed event-triggered optimization algorithm is designed such that the states of robots' hand positions exponentially converge to the optimizer of the global cost function.Meanwhile, the velocity and orientation of each robot are ensured to reach zero and a certain constant, respectively. Moreover, the inter-execution time is lower bounded and the Zeno behavior is therefore naturally avoided. Numerical simulations show the effectiveness of the proposed algorithm. 展开更多
关键词 DISTRIBUTED optimization NONHOLONOMIC ROBOTS event-triggered energy-optimal CONSENSUS
下载PDF
Saponin from Tupistra chinensis Bak Inhibits NF-κB Signaling in Sarcoma S-180 Cell Mouse Xenografts
3
作者 Tai-sheng YE Xiu-ping WANG +2 位作者 Xian-mei zhang Man-ling zhang ying-wen zhang 《Current Medical Science》 SCIE CAS 2018年第4期697-703,共7页
This study examined the effect of saponins from Tupistra chinensis Bak (STCB) on the growth of sarcoma S-180 cells in vitro and in mouse xenografts as well as the underlying mechanisms. Cell proliferation was assess... This study examined the effect of saponins from Tupistra chinensis Bak (STCB) on the growth of sarcoma S-180 cells in vitro and in mouse xenografts as well as the underlying mechanisms. Cell proliferation was assessed by MTT assay. Cell cycle distribution was determined by flow cytometry. Sarcoma S-180 tumor-bearing mice were treated with different doses of STCB with 10 μg/mL 5-fluorouracil (5-Fu) as a positive control. The activity of nuclear factor (NF)-κB was detected by gel mobility shift assay. The mRNA level of NF-κB was determined by real-time quantitative RT-PCR. The results showed that in vitro STCB inhibited the growth of S-180 cells in a concentration-dependent manner, which was accompanied by cell cycle arrest at S-phase. In vivo STCB significantly inhibited the growth of S-180 tumor mouse xenografts in a dose-dependent manner with apparent induction of cell apoptosis. Moreover, STCB inhibited the activity of NF-rd3 p65 and reduced the expression of NF-κB p65 mRNA in mouse xenografts. It was concluded that STCB inhibits the proliferation and cell cycle progression of S- 180 cells by suppressing NF-κB signaling in mouse xenografts. Our findings suggest STCB is a promising agent for the treatment of sarcoma. 展开更多
关键词 Tupistra chinensis Bak S-180 cells proliferation nuclear factor-κB
下载PDF
新型冠状病毒(2019-nCoV)感染的肺炎诊疗快速建议指南(完整版) 被引量:32
4
作者 靳英辉 蔡林 +45 位作者 程真顺 程虹 邓通 范逸品 方程 黄笛 黄璐琦 黄桥 韩勇 胡波 胡芬 李柄辉 李一荣 梁科 林丽开 罗丽莎 马晶 马琳璐 彭志勇 潘运宝 潘振宇 任学群 孙慧敏 王莹 王云云 翁鸿 韦超洁 吴东方 夏剑 熊勇 徐海波 姚晓梅 袁玉峰 叶太生 张笑春 张莹雯 张银高 张华敏 赵剡 赵明娟 訾豪 曾宪涛 王永炎 王行环 武汉大学中南医院新型冠状病毒感染的肺炎防治课题组 《医学新知》 CAS 2020年第1期35-64,共30页
2019新型冠状病毒(2019 novel coronavirus,2019-nCoV)感染的肺炎,因2019年12月发生在武汉的不明原因病毒性肺炎病例而被发现,并于2020年1月12日被世界卫生组织(World Health Organization,WHO)命名。在之后的一个月时间内,2019-nCoV在... 2019新型冠状病毒(2019 novel coronavirus,2019-nCoV)感染的肺炎,因2019年12月发生在武汉的不明原因病毒性肺炎病例而被发现,并于2020年1月12日被世界卫生组织(World Health Organization,WHO)命名。在之后的一个月时间内,2019-nCoV在湖北省内外甚至其他国家传播造成了数以千计的病例出现,同时也引起了民众一定程度的恐慌。本指南的制订希望能够从疾病流行病学、病因学、诊断、治疗、护理、医院感染控制等方面给临床医生、社区居民等提供医疗护理及居家照护相关指导。 展开更多
关键词 2019新型冠状病毒 COVID-19 呼吸疾病 肺炎 感染性疾病 快速建议指南 临床实践指南 循证医学
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部